Correction: Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial

No authors listed

Published Erratum

No authors listed. Cancer Prev Res (Phila). 2016 Jan.

. 2016 Jan;9(1):116-7.

doi: 10.1158/1940-6207.CAPR-15-0373.

No abstract available

Erratum for

Durable antibody responses following one dose of the bivalent human papillomavirus L1 virus-like particle vaccine in the Costa Rica Vaccine Trial.
Safaeian M, Porras C, Pan Y, Kreimer A, Schiller JT, Gonzalez P, Lowy DR, Wacholder S, Schiffman M, Rodriguez AC, Herrero R, Kemp T, Shelton G, Quint W, van Doorn LJ, Hildesheim A, Pinto LA; CVT Group. Safaeian M, et al. Cancer Prev Res (Phila). 2013 Nov;6(11):1242-50. doi: 10.1158/1940-6207.CAPR-13-0203. Cancer Prev Res (Phila). 2013. PMID: 24189371 Free PMC article. Clinical Trial.